Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
World Journal of Urology
Published in: World Journal of Urology 2/2010

01-04-2010 | Topic Paper

Ureteroscopic laser treatment of upper urinary tract neoplasms

Authors: Demetrius H. Bagley, Michael Grasso III

Published in: World Journal of Urology | Issue 2/2010

Login to get access

Abstract

Background

Endoscopic management of upper urinary tract transitional cell carcinoma has assumed an important role in diagnosis and treatment. The introduction of small diameter rigid and flexible ureteroscopes has permitted access to the upper tract. Biopsy techniques have been developed for accurate diagnosis, and the addition of lasers has given the urologists an excellent tool for treatment.

Methods

Medical literature available relative to the endoscopic laser treatment of upper tract neoplasms has been reviewed.

Results

Ureteroscopic treatment has been characterized by good success with high recurrence rates, both in the upper tract and in the bladder. Bladder recurrence rates are similar to those seen after surgical treatment of upper tract tumors. Surveillance has been ureteroscopic since the other diagnostic options are inadequate. The holmium and neodymium:YAG lasers are the devices most commonly used now for the endoscopic treatment of upper tract tumors.

Conclusion

Ureteroscopic treatment of upper tract neoplasms usually with ablation and resection using the neodymium and holmium:YAG lasers is a current acceptable procedure. This should be considered as one of the options in tumor treatment.
Literature
1.
Mazeman E (1972) Les Tumeurs de la Voie Excretice Urinaire Superieure Calices, Bassinet, Uretere. Assoc Franc D’Urol, Paris, Masson et Cie
2.
Babayan RJ, Johnson DE (1980) Primary carcinoma of the ureter. J Urol 123:357–359
3.
Bagley DH, Huffman JL, Lyon ES (1983) Combined rigid, flexible ureteropyeloscopy. J Urol 130:243–244PubMed
4.
Schilling A, Bowering R, Keiditisch E (1986) Use of the neodymium-YAG laser in the treatment of ureteral tumors and urethral condylomata acuminata. Clinical experience. Eur Urol 12(Suppl 1):30–33PubMed
5.
Johnson DE (1994) Use of the holmium:YAG (Ho:YAG) laser for treatment of superficial bladder carcinoma. Lasers Surg Med 14:213–218CrossRefPubMed
6.
Grasso M, Bagley DH (1994) A 7.5/8.2 F actively deflectable, flexible ureteroscope: a new device for both diagnostic and therapeutic upper urinary tract endoscopy. Urology 43:435–441CrossRefPubMed
7.
El-Hakim A, Weiss GH, Lee BR, Smith AD (2004) Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma. Urology 63:647–650CrossRefPubMed
8.
Tawfiek E, Bibbo M, Bagley DH (1997) Ureteroscopic biopsy: technique and specimen preparation. Urology 50:117–119CrossRefPubMed
9.
10.
11.
Argyropoulos AN, Tolley DA (2007) Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches. BJU 99:982–987CrossRef
12.
Bader MJ, Stroka R, Gratzke C et al (2009) Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 56:65–71CrossRefPubMed
13.
Chen GL, Bagley DH (2001) Ureteroscopic surgery for upper tract transitional cell carcinoma: complications and management. J Endourol 15:399–404CrossRefPubMed
14.
Daneshmand S, Quek ML, Huffman JL (2003) Endoscopic management of upper urinary tract transitional cell carcinoma. Cancer 98(1):55–60CrossRefPubMed
15.
Thompson RH, Krambeck AE, Lohse CM et al (2008) Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract. BJUI 102:1107–1110CrossRef
16.
Sowter SJ, Ilie CP, Efthimiou I, Tolley DA (2007) Endourologic management of patients with upper tract transitional cell carcinoma: long term follow up in a single center. J Endourol 21(9):1005–1009CrossRefPubMed
17.
Rassweiler JJ, Schulze M, Marrero R et al (2004) Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery. Eur Urol 46:690–697CrossRefPubMed
18.
Wolf JS, Dash A, Hollenbeck BK et al (2005) Intermediate followup of hand-assisted laparoscopic nephroureterectomy for urothelial carcinoma: factors associated with outcomes. J Urol 173:1102–1107CrossRefPubMed
19.
Okegawa T, Odagane A, Ide S et al (2006) Oncological outcome of retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. Int J Urol 13:493–497CrossRefPubMed
20.
Tsujihata M, Nonomura N, Tsujimura A et al (2006) Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: comparison of laparoscopic and open surgery. Eur Urol 49:332–336CrossRefPubMed
21.
Raman JD, Palese MA, Ng CK et al (2006) Hand-assisted laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. J Soc Lap Surgeons 10:432–438
22.
Chung SD, Chueh SC, Lai MK et al (2007) Long term outcome of hand-assisted laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: comparison with open surgery. J Endourol 21:595–599CrossRefPubMed
23.
Manabe D, Saika T, Ebara S et al (2007) Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology 69:457–461CrossRefPubMed
24.
Muntener M, Nielsen ME, Romero FR et al (2007) Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma. Eur Urol 51:1639–1644CrossRefPubMed
25.
Roupret M, Hupertan V, Sanderson KM et al (2007) Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology 69:656–661CrossRefPubMed
26.
Taweemonkongsap T, Nualyong C, Amornvesukit T et al (2008) Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: Comparison of retroperitoneoscopic and open nephroureterectomy. World J Surg Oncol 6:1–7CrossRef
27.
Waldert M, Remzi M, Klingler HC et al (2009) The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy. BJU Int 103:66–70CrossRefPubMed
28.
Suh RS, Faerber GJ, Wolf JS (2003) Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J Urol 170:2209–2216CrossRefPubMed
29.
Johnson GB, Fraiman M, Grasso M (2005) Broadening experience with retrograde endoscopic management of upper urinary tract urothelial malignancies. BJUI 95(Supp 2):110–113CrossRef
30.
Elashry OM, Elgamasy AK, Sabaa MA et al (2008) Ureteroscopic management of lower ureteral calculi: a 15 year single centre experience. BJU Int 102:1010–1017CrossRefPubMed
31.
Mazeman E (1976) Tumors of the upper tract, calyces, renal pelvis and ureter. Eur Urol 2:120–126PubMed
32.
Zincke H, Neves RJ (1984) Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract. Urol Clin North Am 11:717–724PubMed
33.
Huffman JL, Bagley DH, Lyon ES et al (1985) Endoscopic diagnosis and treatment of upper tract urothelial tumors. A preliminary report. Cancer 55:1422–1428CrossRefPubMed
34.
35.
Low RK, Moran ME, Anderson KR (1993) Ureteroscopic cytologic diagnosis of upper tract lesions. J Endourol 7:311–314CrossRefPubMed
36.
Bagley DH, Kulp DA, Bibbo M (1994) Ureteroscopic biopsy optimized by cytopathologic techniques. J Urol 151:387A
37.
Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH (1997) Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 157:33–37CrossRefPubMed
38.
Malloy TR (1985) Laser treatment of ureter and upper collecting system. In: Smith AD (ed) Lasers in urologic surgery. Year Book, Chicago, pp 82–93
39.
Qureshi AR, Alvesteran A, Divino-Filho JC et al (2002) Inflammation, malnutrition, cardiac diseases as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13:S28PubMed
40.
National Institutes of Health (2008) National Kidney Urologic Diseases Information Clearing House National Institute of Diabetes, Digestive, Kidney Disease. NIH, Bethesda
41.
Snow DC, Bhayani SB (2008) Rapid communication: Chronic renal insufficiency after laparoscopic partial nephrectomy and radical nephrectomy for pathologic t1a lesions. J Endourol 22:337–341CrossRefPubMed
42.
Pak RW, Moskowitz EJ, Bagley DH (2009) What is the cost of maintaining a kidney in upper tract transitional cell carcinoma? An objective analysis of cost and survival. J Endourol 23:341–346CrossRefPubMed
43.
Chen GL, El-Gabry EA, Bagley DH (2000) Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis. J Urol 164:1901–1904CrossRefPubMed
44.
Marin-Aguilera M, Mengual L, Ribal MJ et al (2007) Utility of fluorescence in situ hybridization as a noninvasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol 51(2):409–415 discussion 15CrossRefPubMed
45.
Chen AA, Grasso M (2008) Is there a role for FISH in the management and surveillance of patients with upper tract transitional cell carcinoma? J Endourol 22:1371–1374CrossRefPubMed
46.
Brown GA, Matin SF, Busby JE et al (2007) Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology 70:252–256CrossRefPubMed
47.
Bagley DH, Bibbo M (unpublished observation)
48.
Sylvester RJ, Oosterlinck W, Van der Meijden AP (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with TaT1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171:2186–2190CrossRefPubMed
49.
Eastham JA, Huffman JL (1993) Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. J Urol 150:324–325PubMed
50.
Keeley FX, Bagley DH (1997) Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma. J Urol 158:2074–2077CrossRefPubMed
Metadata
Title
Ureteroscopic laser treatment of upper urinary tract neoplasms
Authors
Demetrius H. Bagley
Michael Grasso III
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
World Journal of Urology / Issue 2/2010
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-010-0525-7

Other articles of this Issue 2/2010

World Journal of Urology 2/2010 Go to the issue

Topic Paper

Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience

Original Article

Minimally invasive vas surgery using a newly designed double-ringed clamp

Original Article

Vascular risk factors and their association to serum androgen levels in a population-based cohort of 75-year-old men over 5 years: results of the VITA study

Original Article

Laparoscopic ureteral reimplantation: prospective evaluation of medium-term results and current developments

Original Article

Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma

Original Article

X-ray-free percutaneous nephrolithotomy in supine position with ultrasound guidance